C4d-positive acute humoral renal allograft rejection: Effective treatment by immunoadsorption

Journal of the American Society of Nephrology

Volumn 12, Issue 11, 2001, Pages 2482-2489

  Bohmig G A ^a   Regele, H ^a   Exner, M ^a   Derhartunian, V ^a   Kletzmayr, J ^a   Saemann M D ^a   Horl W H ^a   Druml, W ^a   Watschinger, B ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; PROTEIN A; THYMOCYTE ANTIBODY;

ADULT; ALLOGRAFT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOADSORPTION; KIDNEY FUNCTION; KIDNEY GRAFT; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034759065     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. The humoral immune response towards HLA class II determinants in renal transplantation
2. Clinical syndromes associated with antibody in allografts
3. Acute humoral rejection in kidney transplantation
4. Anti-HLA antibodies after solid organ transplantation
5. The significance of the anti-class I response: I. Clinical and pathologic features of anti-class I-mediated rejection
6. The significance of the anti-class I response: II. Clinical and pathologic features of renal transplants with anti-class I-like antibody
7. Pathologic features of acute renal allograft rejection associated with donor-specific antibody: Analysis using the Banff grading schema
8. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection
9. Capillary deposition of C 4d complement fragment and early renal graft loss
10. Early renal graft dysfunction. The role of preformed antibodies to DR-typed lymphoblastoid cell lines
11. Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts
12. Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries
13. C4d deposits in renal allografts are associated with inferior graft outcome
14. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation
15. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients
16. Immunoadsorption in acute vascular rejection after renal transplantation
17. Immunoadsorption with protein A in humoral rejection of kidney transplants
18. Protein A immunoadsorption (IA) in renal transplantation patients with vascular rejection
19. Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft
20. The Banff 97 working classification of renal allograft pathology
21. Expression of the C-C chemokine receptor 5 in human kidney diseases
22. Microdroplet assay of human serum cytotoxins
23. Posttransplant antidonor lymphocytotoxic antibody production in relation to graft outcome
24. Evidence demonstrating poor kidney graft survival when acute rejections are associated with IgG donor-specific lymphocytotoxin
25. Biochemical characterization of human vascular endothelial cell-monocyte antigens defined by monoclonal antibodies
26. The clinical significance of allospecific antibodies against endothelial cells detected with an antibody-dependent cellular cytotoxicity assay for vascular rejection and graft loss after renal transplantation
27. An association between antibodies specific for endothelial cells and renal transplant failure
28. Detection of alloantibodies by flow cytometry: Relevance to clinical transplantation
29. Flow cytometry analysis: A high technology crossmatch technique facilitating transplantation
30. The prospective value of the preoperative flow cytometric crossmatch assay in renal transplantation
31. The flow cytometric crossmatch and early renal transplant loss
32. Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients
33. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation